Dietary management drugs have transformed Type 2 diabetes care, but daily injection routines are challenging for some patients. A new hydrogel could mean shots just three times a year.
A new Stanford study uses behavioral analysis, neural engineering, electrophysiology, and math to explore how mice decide whether to eat or drink when they are both hungry and thirsty.
A new study that combines genetic and molecular techniques helps solve the riddle of starfish body plans, and how starfish start life with bilateral body symmetry – just like humans – but grow up to be adults with fivefold “pentaradial” symmetry.
Stanford researchers who previously pioneered a new kind of protein degradation have mapped out how the process works, which could lead to new drug therapies for diseases like Alzheimer’s and cancer, and for rare childhood enzyme disorders.
Considered inert and deemed safe for consumption by the Food and Drug Administration, silica has been shown to react with key biomolecules, potentially degrading their function.
Sugar-coated proteins called mucins are implicated in many diseases, including cancer. A Stanford-led team has bioengineered an enzyme-based scissors that selectively cuts mucins off cancer cells, removing their “cloak of protection” from the body’s immune system.
By tinkering with the material makeup of perovskite LEDs, a cheaper and more easily-made type of LED, Stanford researchers achieved leaps in brightness and efficiency – but saw their lights give out after a few minutes of use.
